AKT is phosphorylated by PI3K and becomes activated, and phospho-AKT can bind and regulate many downstream effectors such as BCL-2 family proteins which play a protective role against NAFLD development (Matsuda et al., 2013). The gene discussed is BCL2; the disease is metabolic dysfunction-associated steatotic liver disease.